Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway (Onco-PREMs)

NCT06356363 | Not Yet Recruiting

• 1 other identifier: 2023_RIPH_005_OncoPREMs
• Study Type: observational
• Target: 500
• Locations: 0 countries
• Sites: N/A

Brief Summary

Healthcare systems are evolving, giving increasing prominence to the patient-centered model, accompanied by objective and perceived outcomes. PREMs (Patient Reported Experience Measures) are used to assess how patients feel about their experience of care. PREMs enable patients to take an active role in their own care, and enable healthcare establishments to identify areas for improvement that can be incorporated into their quality processes. In oncology, the collection of patient-perceived quality regarding their care pathway would enable better coordination of their care. While a few initiatives have emerged in the field of PREMs, the development of a reliable questionnaire assessing patient perception of their care pathway in oncology remains a challenge.

Conditions

Cancer

Keywords

Oncology; oncology care pathway; patients' perception; questionnaire; psychometric validation

Outcome Measures

Primary Outcomes (1)

• Psychometric validation

  Stastistical analysis to confirm the psychometric validation of the IGQ questionnaire

  Day 0

Study Arms (1)

Cancer patient

Patient with cancer regardless of location or stage.

Other: Data collection

Interventions

Data collection OTHER

data collection

Cancer patient

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patient with cancer regardless of location or stage.

You may qualify if:

• cancer patient
• regardless of location or stage
• Fluent in French
• aged more than 18 years old
• Agreeing to take part in the study

You may not qualify if:

• With an estimated life expectancy of less than 3 months
• In remission, untreated or without follow-up for more than 12 months
• Protected by law

Sponsors & Collaborators

• Institut Jean-Godinot: lead
• Université de Reims Champagne-Ardenne: collaborator

MeSH Terms

Conditions

Neoplasms

Interventions

Data Collection

Intervention Hierarchy (Ancestors)

Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• DIOURI Loubna

  Institut Godinot

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Barbe Coralie, DR

CONTACT

0326918822; coralie.barbe1@univ-reims.fr

Gestonnairedu CURRS, Dr

CONTACT

0326918822; currs@univ-reims.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 4, 2024
• First Posted: April 10, 2024
• Study Start: June 1, 2024
• Primary Completion: November 1, 2025
• Study Completion: November 1, 2025
• Last Updated: April 10, 2024

Record last verified: 2024-04